Further re Grant Application

28 April 2010

HENDERSON MORLEY PLC

(AIM: HML)

FURTHER RE GRANT APPLICATION

The Board of Henderson Morley plc ("Henderson Morley"), the AIM quoted biotechnology company, announces that, following its application for Grant Funding from the Queensland Government funded Research Industry Partnership Programme ("RIPP") as announced on 5 November 2009, it has been notified by the Queensland Institute of Medical Research ("QIMR") that the application has been unsuccessful, even though it was short listed.

The Cytomegalovirus Vaccine funding was not granted due to a shortage of funds within RIPP despite having been recommended to the Minister of Health.

Commenting, Andrew Knight, Henderson Morley's Executive Chairman, said "We continue to make applications for Grant funding both in the UK and Overseas and whilst we are disappointed not to have been successful on this occasion, we remain optimistic that we will receive Grant Funding in the future."

-END-

Enquires

HENDERSON MORLEY PLC 0121 442 4600

Andrew Knight, Chairman

BISHOPSGATECOMMUNICATIONS LTD 0207 562 3350

Maxine Barnes

Gemma O'Hara

BREWIN DOLPHIN INVESTMENT BANKING 0113 241 0126

Neil Baldwin

RIVINGTON STREET CORPORATE FINANCE 0207 562 3380

Leo Godsall

Further information on Henderson Morley plc can be accessed through the Company's website at www.henderson-morley.com